Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1 CNS 1

Conditions

Neuroblastoma 44 Ganglioneuroblastoma 5 Medulloblastoma 4 Glioblastoma 4 Brain Neoplasms 4 Gliosarcoma 3 Glioma 3 Central Nervous System Neoplasms 3 Astrocytoma 3 Rhabdoid Tumor 2 Recurrence 2 Pinealoma 2 Oligodendroglioma 2 Pyloric Stenosis, Hypertrophic 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Neuroendocrine Tumors 1 Neuroectodermal Tumors, Primitive 1 Neoplasms 1 Neoplasm, Residual 1 Lymphoma, Large B-Cell, Diffuse 1 Leukemia, Myelomonocytic, Juvenile 1 Ependymoma 1 Dendritic Cell Sarcoma, Interdigitating 1 Burkitt Lymphoma 1

Interventions

Temozolomide 19 Bevacizumab 14 Irinotecan 12 Carboplatin 10 Cyclophosphamide 9 Radiosurgery 8 Lomustine 8 Radiotherapy 7 pembrolizumab 6 Vincristine 6 Topotecan 6 Drug Therapy 6 Surgical Procedures, Operative 5 Etoposide 5 Doxorubicin 5 Cisplatin 5 3-Iodobenzylguanidine 5 trametinib 4 Metformin 4 Gemcitabine 4 Dexamethasone 4 Blood Specimen Collection 4 poly ICLC 3 dabrafenib 3 Vorinostat 3 Trastuzumab 3 Therapeutics 3 Radiation 3 Paclitaxel 3 Observation 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasms × Isotretinoin × CNS × Clear all

NCT00135135 2008-06-03

Therapy for Children With Neuroblastoma

St. Jude Children's Research Hospital

Phase 2 Completed

Neoplasms, Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡